Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo
Pharmacology for Nurses

Chapter 11

Pharmacology for NursesChapter 11

Case Study

1.
c. This is concerning because this drug has the potential to exacerbate dysrhythmias.
2.
a. This drug is a cholinergic blocker (anticholinergic). According to the Beers Criteria®, these drugs should not be used in those over the age of 60 years and with a history of BPH that causes urinary retention. This could worsen from the anticholinergic.

Review Questions

1.
b. The nurse is evaluating the therapeutic effectiveness of the drugs. The client being able to perform more activities of daily living indicates the drugs are working.
2.
b. Because the client cannot swallow well, this drug is the best to meet their needs. It is available in a patch form and is administered transdermally.
3.
c. This client is experiencing neuroleptic malignant syndrome.
4.
c. This drug can be used to manage relapses in clinically isolated syndrome (CIS), primary progressive (PPMS), relapsing-remitting (RRMS), and secondary progressive (SPMS).
5.
a. Insomnia occurs with this drug because it metabolizes to methamphetamine and amphetamine, causing stimulation. If taken too late in the day, sleep could be disrupted.
6.
c. This drug can exacerbate tuberculosis. If a tuberculin skin test and chest radiograph (x-ray) are positive, the client must be treated for TB before starting the prescribed drug.
7.
b. High-protein meals will interfere with levodopa absorption and entrance into the brain.
8.
d. This drug causes euphoria, which can diminish impulse control.
9.
c. Benztropine is an anticholinergic. One of the adverse effects of this classification is the potential to increase intraocular pressure; therefore, it should be avoided in clients with glaucoma.
10.
a. These block dopamine receptors in the striatum, resulting in diminished therapeutic effects of levodopa and augmented Parkinsonian symptoms.
PreviousNext
Order a print copy
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.